APA (7th ed.) Citation

Brighi, N., Lamberti, G., Andrini, E., Mosconi, C., Manuzzi, L., Donati, G., . . . Campana, D. (2023). Prospective Evaluation of <i>MGMT</i>-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors. MDPI AG.

Chicago Style (17th ed.) Citation

Brighi, Nicole, Giuseppe Lamberti, Elisa Andrini, Cristina Mosconi, Lisa Manuzzi, Giada Donati, Andrea Lisotti, and Davide Campana. Prospective Evaluation of <i>MGMT</i>-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors. MDPI AG, 2023.

MLA (9th ed.) Citation

Brighi, Nicole, et al. Prospective Evaluation of <i>MGMT</i>-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors. MDPI AG, 2023.